HealthEquity (HQY) Tops Q4 EPS by 5c, FY EPS Guidance Misses

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $75.8 million versus the consensus estimate of $74.09 million.

GUIDANCE:

HealthEquity sees FY2020 EPS of $1.23-$1.29, versus the consensus of $1.31. HealthEquity sees FY2020 revenue of $333-339 million, versus the consensus of $336.33 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
• AptarGroup (ATR) Tops Q1 EPS by 11c
• COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance